MRNA - Moderna, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
18,875,000
19,263,000
17,736,000
274,490
48,036
Cost of revenue
5,416,000
5,416,000
2,617,000
7,933
-
Gross profit
13,459,000
13,847,000
15,119,000
266,557
-
Operating expenses
Research development
3,295,000
3,295,000
1,991,000
1,370,339
496,309
Selling general and administrative
1,132,000
1,132,000
567,000
188,267
109,620
Total operating expenses
4,039,000
4,427,000
1,823,000
1,029,701
593,756
Operating income or loss
9,420,000
9,420,000
13,296,000
-763,144
-545,720
Interest expense
29,000
29,000
18,000
9,886
6,612
Total other income/expenses net
-16,000
-45,000
-29,000
-6,084
-7,526
Income before tax
9,575,000
9,575,000
13,285,000
-744,513
-514,716
Income tax expense
1,213,000
1,213,000
1,083,000
2,551
-695
Income from continuing operations
8,362,000
8,362,000
12,202,000
-747,064
-514,021
Net income
8,362,000
8,362,000
12,202,000
-747,064
-514,021
Net income available to common shareholders
8,362,000
8,362,000
12,202,000
-747,064
-514,021
Basic EPS
-
21.26
30.31
-1.96
-1.55
Diluted EPS
-
20.12
28.29
-1.96
-1.55
Basic average shares
-
394,000
403,000
381,000
331,000
Diluted average shares
-
416,000
431,000
381,000
331,000
EBITDA
-
9,768,000
13,296,000
-763,144
-545,720